• The Meaning of Rate Review

    Updated: 2011-12-30 20:30:12
    This is Robert Book, writing at the Apothecary: The Affordable Care Act does not define what it means for a premium increase to be “unreasonable,” but the administration defined it in a regulation issued in May. An increase is defined as “unreasonable” if it is “more than 10%.” (76 FR 29964). So, if a health [...]

  • 2011 marked by tragedy, controversy – The Tennessean

    Updated: 2011-12-30 20:00:15
    2011 marked by tragedy, controversyThe TennesseanCommissioners voted to adopt the 1981 Financial Management Act, putting the school system's finance department under the leadership of County Finance Director David Lawing. While the move created many heated debates, it was never formally enacted and … Go here to read more: “outsourcing” and “finance” – Google News

  • Europe’s Insurers Struggle for Life (Wall Street Journal)

    Updated: 2011-12-30 19:00:30
    Share With Friends: | | Business – Markets – World Markets News, RSS Feeds and Widgets via Feedzilla. Go here to read more: Feedzilla: Markets – World Markets News

  • Virtual Employee Offering Dedicated Staffing Solution for Total Outsourcing Needs – SBWire (press release)

    Updated: 2011-12-30 19:00:05
    Virtual Employee Offering Dedicated Staffing Solution for Total Outsourcing NeedsSBWire (press release)VirtualEmployee.com (the prominent Indian outsourcing company) offers dedicated staffing solution to cater total outsource needs. Wilmington, DE — (SBWIRE) — 12/30/2011 — Outsourcing of crucial business processes is an essential need for … Go here to read more: “outsourcing” – Google News

  • Putting Everything Out to Bid

    Updated: 2011-12-30 18:30:52
    One of the main advantages of Medicare FFS [fee for service] is that beneficiaries do not need a referral for any services and are not limited to certain provider networks. However, Medicare beneficiaries do not pay for these added benefits. In addition, even if HMOs are more efficient than Medicare FFS, Medicare FFS beneficiaries still [...]

  • Top 10 Unfounded Health Scares of 2011

    Updated: 2011-12-30 16:30:52
     1. The HPV Vaccine 2. Apple Juice 3. Gulf Coast Fish 4. Hydraulic Fracturing, or “Fracking” 5. Sunscreen 6. Fluoridated Water 7. Cell Phones 8. Genetically Modified Fish 9. Fragrances 10. Phthalates See in-depth breakdown of each scare at the American Council on Science and Health’s website. HT to John Dunn.  

  • Headlines I Wish I Hadn’t Seen

    Updated: 2011-12-30 15:30:19
    90% of U.S. bank notes carry traces of cocaine. The government will pay for a lifetime of dialysis ($75,000 a year) for an illegal alien, but not for the $100,000 transplant that would make it unnecessary. Nearly One in Three Will Be Arrested by Age 23.  

  • Physicians are paid less to give combination vaccines

    Updated: 2011-12-30 14:50:48
    [amenews] Medical practices generally earn less giving a single shot that protects against five diseases than injecting component immunizations separately, even though the same amount of counseling time is often required for combination shots as single vaccinations, according to a study. Lower payment for administering combination vaccines is problematic because these ...

  • DrRich’s Top Ten of 2011

    Updated: 2011-12-30 14:33:53
    After extensive analysis by a committee of hand-picked experts, with much debate and with some dissension, the following have been identified as DrRich’s Top Ten Posts of 2011. Ten: The Right To Bear Salt Nine: About Those Doctor-Nurses Eight: The Four Ways To Reduce Healthcare Spending Seven: On Killing The Elderly Six: The Real Utillity [...]

  • John Goodman’s Health Policy Blog’s 10 Most Popular Posts from 2011

    Updated: 2011-12-30 14:15:16
    What Most Needs Repealing and Replacing Health Problem Quantified Is Medicare a Good Deal? Bad News for ObamaCare Are Market-Oriented Economists Wrong About Health Care? Krugman Gets It Wrong Again Is RomneyCare Different from ObamaCare? This one was written by one of our talented guest authors, Linda Gorman. Why Do We Need Unions? What Is [...]

  • Families of Ill Children Try Drug Development .

    Updated: 2011-12-29 21:50:44
    [WSJ] After an Israeli biotech company stopped working on a promising medication, two U.S. families took an unusual step: They bought the drug and decided to develop it themselves as a possible treatment for their children's muscular dystrophy. The Secklers, of Stockbridge, Mass., and the Wicka family, from Minneapolis, are hoping ...

  • The Cost of Saving Lives

    Updated: 2011-12-29 20:30:03
    Using cardiovascular disease as an example, [the authors] note that 44 percent of the reduction in mortality from 1980 to 2000 was due to improved health behaviors. Another 22 percent of the decline was due to inexpensive Category I treatments such as aspirin and beta blockers, 12 percent was due to Category II treatments like [...]

  • Nursing Pays

    Updated: 2011-12-29 19:30:08
    The U.S. Bureau of Labor Statistics (BLS) predicts that the registered nurse (RN) will be the fastest growing profession between 2008 and 2018. And the profession is financially rewarding. The BLS estimates that the average salary for a registered nurse in 2010 was $67,720, or $32.56 an hour. In 2009 the average salary was $63,750, [...]

  • FDA notes risks of birth control pills, will consult expert panel

    Updated: 2011-12-29 19:18:15
    , Skip to navigation Skip to content Jump to Navigation FDA notes risks of birth control pills , will consult expert panel On behalf of Tracey Law Firm posted in Dangerous Drugs 29 December 2011 Earlier this month , the Food and Drug Administration released documents stating that new information about the risk of blood clots from new contraceptive drugs may result in increased warnings on labels of popular birth control pills like . Yaz Yaz and several other birth control pills containing the hormone drospirenone been implicated by a growing body of evidence that newer contraceptive drugs may pose more risks than older ones . The evidence flies in the face of marketing messages that have said newer contraceptives are safer than previous . ones Because of this , the FDA will be seeking the

  • Is Salt a Public Health Danger?

    Updated: 2011-12-29 18:30:37
    Last year, the government’s Institute of Medicine urged the Food and Drug Administration to “gradually step down the maximum amount of salt that can be added to foods, beverages and meals.” The FDA is listening. In September, it published a notice concerning issues “associated with the development of targets for sodium reduction in foods to [...]

  • What Difference Do Advance Directives Make?

    Updated: 2011-12-29 16:30:28
    The results were surprising: The advance directives only saved money in areas where Medicare’s end-of-life costs are high. Think Florida and New York. In areas where Medicare’s costs are already low — say, Minnesota — there was no change in spending…. The big difference, in fact, was that patients with end-of-life directives in high-costs areas [...]

  • What Happened to the Federal Risk Pools?

    Updated: 2011-12-29 15:30:52
    This is Sarah Kliff (at Ezra Klein’s blog): The crowds never showed and the program’s enrollment has lagged far behind projections. The chief actuary for Medicare initially estimated that 375,000 people would sign up by the end of 2010. As of Oct. 1, only 41,427 have enrolled. A new report from the Government Accountability Office [...]

  • A.M. Vitals: Study Questions Genetic Test for Plavix

    Updated: 2011-12-28 14:04:46
    Also: the cost of failed metal-on-metal artificial hips; helping baby boomer workers stay fit; how appropriate is care in the ICU?

  • Thalidomide drug firm sued over Australian birth defects

    Updated: 2011-12-27 19:16:40
    Skip to navigation Skip to content Jump to Navigation Thalidomide drug firm sued over Australian birth defects On behalf of Tracey Law Firm posted in Dangerous Drugs 27 December 2011 Efforts by the German drug manufacturer Grunenthal to have a class action products liability lawsuit filed against it by Australian women and their children has been defeated . An Australian court ruled that the plaintiffs had the right to have their claims adjudicated in their own country's courts . The lawsuit involves numerous birth defects the plaintiffs say were caused by the drug . Thalidomide The drug was used by pregnant women during the decade of the 1950s , as well as early in the 1960s . Following indications that it caused horrible birth defects it was removed from sale . Thousands of children

  • Accutane Bowel Injury Lawsuit Ends with Hung Jury

    Updated: 2011-12-27 13:26:28
    Drug Recall Lawyer Blog Published by Miller Zois , LLC Home Website Practice Areas Contact Us Home Drugs Accutane Bowel Injury Lawsuit Ends with Hung Jury Previous Home Posted On : December 27, 2011 by Ronald V . Miller , Jr . Accutane Bowel Injury Lawsuit Ends with Hung Jury Share Another Accutane lawsuit in New Jersey ended on Thursday , this time with a hung jury instead of the usual : a big plaintiffs' verdict . The jury had been out for a week the trial lasted three weeks . Accutane's manufacturer Hoffman-La Roche said in a press statement that it is pleased that the jury concluded that plaintiff Tanna was unable to prove her case . It said it looks forward to a retrial . I guess if you are wearing rose colored glasses , that is how you would see it . Hoffman-La Roche is taking a

  • $327 Million Risperdal Verdict Upheld

    Updated: 2011-12-23 18:45:27
    Drug Recall Lawyer Blog Published by Miller Zois , LLC Home Website Practice Areas Contact Us Home Johnson Johnson 327 Million Risperdal Verdict Upheld Previous Home Next Posted On : December 23, 2011 by Ronald V . Miller , Jr . 327 Million Risperdal Verdict Upheld Share As expected , the South Carolina trial judge denied post-trial motions to overturn a 327 million civil penalty against Johnson Johnson , which was found to have overstated the claims about its antipsychotic drug , Risperdal . The award was 4,000 for each of more than 43,000 letters pushing Risperdal that J sendt to doctors , plus 300 each for 509,000 free samples given to doctors that contained detailed package inserts . Still , J made a fortune off of Risperdal , pulling in as much as 3.4 billion a year in sales . Think

  • Drug and Device Safety News

    Updated: 2011-12-23 18:28:24
    Drug Recall Lawyer Blog Published by Miller Zois , LLC Home Website Practice Areas Contact Us Home Drug and Device Safety News Previous Home Next Posted On : December 23, 2011 by Ronald V . Miller , Jr . Drug and Device Safety News Share The Justice Department has recovered 2.2 billion in civil enforcement actions against pharmaceutical companies this year . Yes , Tylenol , even at safe levels , can hurt you The FDA has warned California Lap-Band practices to stop it with the misleading ads The FDA says it's premature to draw any link between SSRIs during pregnancy and babies with a condition called persistent pulmonary hypertension of the newborn . Pfizer has to pay three women who alleged a link between hormone replacement drugs and their breast cancer . : HT TortsPro f . Posted by

  • Liquid Acetaminophen for Infants

    Updated: 2011-12-23 13:54:21
    Drug Recall Lawyer Blog Published by Miller Zois , LLC Home Website Practice Areas Contact Us Home Children Drug Warnings Liquid Acetaminophen for Infants Previous Home Next Posted On : December 23, 2011 by Ronald V . Miller , Jr . Liquid Acetaminophen for Infants Share The FDA is advising that an additional concentration of liquid acetaminophen marketed for infants” is now available . The new concentration , 160 mg 5 ml , will affect the amount of liquid given to an infant , and should be especially noted by consumers who re used to using the 80 mg 0.8 mL or 80 mg mL concentrations of liquid . acetaminophen The Over-the-Counter OTC Liquid acetaminophen is used to temporarily reduce fever and relieve minor aches and pains due to the common cold , flu , headache , minor sore throat , and

  • Recalled Motrin IB Tablets and Caplets

    Updated: 2011-12-23 13:38:17
    Drug Recall Lawyer Blog Published by Miller Zois , LLC Home Website Practice Areas Contact Us Home Drugs Johnson Johnson Recalled Motrin IB Tablets and Caplets Previous Home Next Posted On : December 23, 2011 by Ronald V . Miller , Jr . Recalled Motrin IB Tablets and Caplets Share Johnson Johnson , eager to pad its record recall year before 2011 closes out , is recalling certain lots of MOTRIN IB because testing of product samples showed that some caplets may not dissolve as quickly as intended when nearing their expiration date . This is not a consumer level recall , meaning consumers do not need to dispose of or return the . product There is no safety concern if consumers continue taking the product in accordance with its label there may just be a delay in experiencing relief . The

  • Gilenya Concern

    Updated: 2011-12-23 10:47:09
    Drug Recall Lawyer Blog Published by Miller Zois , LLC Home Website Practice Areas Contact Us Home Drug Warnings Gilenya Concern Previous Home Next Posted On : December 23, 2011 by Ronald V . Miller , Jr . Gilenya Concern Share The FDA Safety Information and Adverse Event Reporting Program has announced that the FDA has received a report of a patient with multiple sclerosis MS who died within 24 hours of taking the first dose of Gilenya fingolimod Gilenya is an oral medication for the treatment of relapsing forms of Multiple Sclerosis MS in adults , and is used to reduce the frequency of flare-ups and delay physical disability . The FDA believes as do most neurologists that Gilenya provides an important health benefit when used as directed , and recommends that healthcare professionals who

  • Medical device manufacturer sues Kentucky surgeon, P.2

    Updated: 2011-12-22 18:31:06
    , Skip to navigation Skip to content Jump to Navigation Medical device manufacturer sues Kentucky surgeon , P.2 On behalf of Tracey Law Firm posted in Medical Malpractice 22 December 2011 In our last post , we began discussing a lawsuit recently filed by a medical device manufacturer against Kentucky . surgeon While the suit is still ongoing in Kenton Circuit Court in Kentucky , it does bring up interesting questions regarding expectations of doctors . In particular , the suit raises the question of whether doctors should be held responsible for seeking out information concerning changes to medication instructions or whether medical device manufacturers should announce updates to . physicians Defense attorneys tend to say that doctors are responsible for staying current with respect to

  • Blast from the Olympia Past: David Pattillo with Dead Exs Band in New York

    Updated: 2011-12-21 18:31:21
    One of the interesting things about social media is catching up with people from your past and finding out what they are doing now. I have caught up with quite a few people who have spread out all over the globe and whom I would have never have heard from otherwise. One of the friends [...]

  • 2011’s New Medicines Fought Wide Range of Diseases, Conditions

    Updated: 2011-12-21 17:45:03
    After a momentous year, Washington is readying itself for holiday vacation. There’ no better indication than my traffic-free commute over the bridge – it was, dare I say, relaxing. I welcome the slower pace not just for the liberation from gridlock; it’ a chance to reflect on the year. read more

  • President’s Bioethics Commission Releases Report on Human Subjects Protection: Current regulations are robust, but should be improved

    Updated: 2011-12-21 04:29:05
    WASHINGTON, D.C. – The Presidential Commission for the Study of Bioethical Issues today issued its report concerning federally-sponsored research involving human volunteers, concluding that current rules and regulations provide adequate safeguards to mitigate risk.  In its report, “Moral Science: Protecting Participants in Human Subjects Research," the Commission also recommended 14 ...

  • Supreme Court hears arguments in drug patent cases

    Updated: 2011-12-21 04:29:04
    [AmedNews] U.S. Supreme Court justices in December heard oral arguments in two high-profile patent cases that could have widespread effects on patients who need certain drugs. In Mayo Collaborative Services v. Prometheus Laboratories Inc., the high court is weighing whether a test that measures patients' metabolite levels to determine drug dosages ...

  • Medical device manufacturer sues Kentucky surgeon, P.1

    Updated: 2011-12-20 18:29:08
    , Skip to navigation Skip to content Jump to Navigation Medical device manufacturer sues Kentucky surgeon , P.1 On behalf of Tracey Law Firm posted in Medical Malpractice 20 December 2011 Are doctors expected to seek information concerning changes to medication instruction or updated information concerning medical devices That is the question being raised in a lawsuit filed by a pain pump manufacturer against a Kentucky orthopedic . surgeon The surgeon in question had apparently performed reconstructive surgery on a patient and implanted a pain pump in the patient's should to administer pain medication directly to his shoulder joint . The patient was later diagnosed with chondrolysis , a condition which can be caused by continuous administration of certain anesthetics directly to the

  • Big Pharma v. The Truth

    Updated: 2011-12-18 23:40:55
    A review of Goose That Laid the Golden Egg by freelance writer Bob Etier, follow her on twitter @katelier, and read the full review here. Did you know that Vitamin A, taken in excess, is believed to cause depression? Accutane, that remarkably popular drug once prescribed to teens and still available in generic form, is a [...]

  • Book Review: The Beauregarde Affair, by Brian Talgo

    Updated: 2011-12-15 23:04:53
    The Beauregarde Affair is great narrative nonfiction about the author’s time in the 1970s living with his sex drug and rock and roll friends in a house on North Morningside Drive in Atlanta, GA. The author and his friends lived in a stately older home in the Morningside neighborhood of Atlanta while they carried on [...]

  • What to Read: WCG's Brian Reid on Social Media and the FDA

    Updated: 2011-12-15 20:15:12
    On the Pharmalot blog, Ed Silverman published an interesting op-ed by Brian Reid, a social media expert with WCG, about the lack of FDA guidance on social media.  He presents a clear overview of where we stand in terms of use of social media, as well as the process that led us here (for instance, the repeated promises from FDA about a guidance, none of which the agen read more

  • On the Road to Talk About Clinical Trials and Their Impact on States

    Updated: 2011-12-15 13:49:33
    Here at PhRMA, I’ known as a bit of a road warrior.  here’ nothing I enjoy more than leaving Washington, D.C. read more

  • Sassy Peach, Book Reviewer: The Goose That Laid the Golden Egg

    Updated: 2011-12-14 22:24:29
    Book Review reposted from Sassy Peach Book Reviewer. Read more book reviews here and follow her blog here and twitter @niccilor here. I was attracted to The Goose That Laid The Golden Egg by Doug Bremner because it is the story of the psychiatrist who took down Accutane. You know, that drug that the pharmaceutical [...]

  • What to Watch: HIV/AIDS Medicines in Development

    Updated: 2011-12-14 21:09:33
    Hear from Dr. John Pottage, the chief scientific and medical officer for ViiV Healthcare,  ho has been in the battle against HIV/AIDS since before we even identified the disease. He discusses the improvements that new medicines and therapies have made for patients. But with a new infection occurring every nine and a half minutes, more needs to be done. read more

  • November 2011 Medication Label Changes

    Updated: 2011-12-14 15:29:02
    Drug Recall Lawyer Blog Published by Miller Zois , LLC Home Website Practice Areas Contact Us Home Drug Warnings November 2011 Medication Label Changes Previous Home Next Posted On : December 14, 2011 by Ronald V . Miller , Jr . November 2011 Medication Label Changes Share Last month brought changes to forty-eight 48 medical product labels holding steady with 48 changes in October with changes to the prescribing information to include any of the following areas : boxed warnings , contraindications , warnings , precautions , adverse reactions , patient package insert , and medication . guide For a complete detailed accounting of the label changes , please refer to the summary of meds . By clicking onto the drug name , you will be able to view the detailed summary , which will identify the

  • Yaz/Yasmin: FDA Reviews Bayer’s Warnings

    Updated: 2011-12-13 20:04:18
    : Drug Recall Lawyer Blog Published by Miller Zois , LLC Home Website Practice Areas Contact Us Home Bayer Yasmin Yaz Yaz Yasmin : FDA Reviews Bayer’s Warnings Previous Home Next Posted On : December 13, 2011 by Ronald V . Miller , Jr . Yaz Yasmin : FDA Reviews Bayer’s Warnings Share Several FDA groups met on December 8 to review warnings on Bayer’s five drospirenone-containing birth control pills . This meeting is the product of several months of mounting evidence that these birth control pills are unreasonably dangerous , particularly in light of safer alternatives . First a review : Bayer through Berlex , a company later enveloped by Bayer developed and released Yasmin in May 2001. Ocella , manufactured by Barr Laboratories , is the generic of Yasmin . These drugs contain an active

  • Philadelphia women awarded $72.6 million against Pfizer, P.1

    Updated: 2011-12-13 17:34:53
    , Skip to navigation Skip to content Jump to Navigation Philadelphia women awarded 72.6 million against Pfizer , P.1 On behalf of Tracey Law Firm posted in Dangerous Drugs 13 December 2011 Last Tuesday , a Philadelphia Common Pleas Court awarded several women a total of 72.6 million in compensatory damages in a suit they had filed against pharmaceutical giant Pfizer . The women's suits were originally filed in July 2004 against Wyeth Pharmaceuticals and Pharmacia Upjohn . Both of those companies have since been acquired by . Pfizer The women apparently claimed their breast cancer diagnoses were connected to their consumption of hormone therapy medications , including Prempro . The drugs were designed to treat menopause . symptoms One of the plaintiffs , a 66-year-old woman , had taken

  • Bill Would Make Drug Price Gouging a Federal Crime

    Updated: 2011-12-13 17:07:38
    [PharmaPro] TRENTON, N.J. (AP) — Price gouging on prescription drugs already in short supply would become a federal crime under legislation about to be introduced. Sen. Charles E. Schumer, D-N.Y., said he's proposing a bill that that would give the U.S. Department of Justice authority to crack ...

  • US revisits safety of newer birth control drugs

    Updated: 2011-12-13 17:07:36
    [PharmaPro] Birth control drugs that were heavily promoted as having fewer side effects and the ability to clear up acne and other hormonal bothers are under new scrutiny from U.S. safety regulators. Research suggesting that newer birth control formulations are more likely to cause blood clots than ...

  • What to Read: John Castellani on America’s Export Economy

    Updated: 2011-12-13 14:48:22
    In The Hill’ CongressBlog, PhRMA President and CEO John J. Castellani had an op-ed today about how our federal efforts to stimulate economic growth will undoubtedly lack the momentum they need without a related emphasis on exports – and the biopharmaceutical sector, already a major generator of exports, can help. But we need support.  He writes: “Leadership is needed to help keep U.S. read more

  • Increased Biopharma Research Industry Investment in Neglected Disease

    Updated: 2011-12-12 21:06:16
    I recommend taking a look at the new G-FINDER: YEAR 4 report on Neglected Disease Research and Development. Unfortunately, the report describes how funding for neglected disease research by governments and many NGOs declined over the last year. read more

  • Stronger Label Urged for Birth Control Products, Yaz and Yasmine

    Updated: 2011-12-12 13:39:39
    , Drug Recall Lawyer Blog Published by Miller Zois , LLC Home Website Practice Areas Contact Us Home Drug Warnings FDA Yasmin Yaz Stronger Label Urged for Birth Control Products , Yaz and Yasmine Previous Home Next Posted On : December 12, 2011 by Ronald V . Miller , Jr . Stronger Label Urged for Birth Control Products , Yaz and Yasmine Share An advisory committee to the Food and Drug Administration has met to discuss popular birth control pills such Yas and Yasmin , and has concluded that the information on the labels should be strengthened . Currently , the labels suggest that these contraceptives have blood clot risks similar to those of other birth control pills that combine estrogens and progestins . The panel , which voted 21 to 5 in favor of changing the labels , has said the labels

  • Goal: Zero New AIDs Cases

    Updated: 2011-12-09 16:58:48
    I recommend taking a look at the Business World Weekender discussion for World AIDs Day: “Getting to Zero.” The campaign’ goal is to have zero new infections, zero discrimination and zero AIDS related deaths. While the article focuses on the Asia Pacific region it is important to keep in mind that this is a disease without boundaries. read more

  • Doctors and patients need to monitor medication usage better

    Updated: 2011-12-07 20:52:15
    Skip to navigation Skip to content Jump to Navigation Doctors and patients need to monitor medication usage better On behalf of Tracey Law Firm posted in Dangerous Drugs 07 December 2011 According to researchers , elderly persons and their doctors need to be more careful in monitoring medications taken for chronic conditions in order to ensure they're working like they should . While this may seem obvious , things don't always work out that . way A recent study published in the New England Journal of Medicine looked at nearly 100,000 emergency hospitalizations for adverse drug reactions and found that four categories of medications were responsible for third-thirds of emergency room visits in persons over 65 years of age . Those categories were the blood thinner warfarin , anti-platelet

  • FDA Evaluates Pradaxa For Reports of Serious Bleeding Events

    Updated: 2011-12-07 18:36:49
    Drug Recall Lawyer Blog Published by Miller Zois , LLC Home Website Practice Areas Contact Us Home FDA FDA Evaluates Pradaxa For Reports of Serious Bleeding Events Previous Home Next Posted On : December 7, 2011 by Ronald V . Miller , Jr . FDA Evaluates Pradaxa For Reports of Serious Bleeding Events Share The FDA is evaluating post-marketing reports of serious bleeding events in patients that are taking Pradaxa dabigatran etexilate mesylate Pradaxa , a blood thinning anticoagulant medication used to reduce the risk of stroke in patients with non-valvular atrial fibrillation AF contains a drug label that warns about significant and sometimes fatal bleeds , bleeding that may lead to serious or even fatal . outcomes In a large clinical trial involving 18,000 patients , Pradaxa and warfarin

  • Despite HHS Secretary Sebelius's Interest, Still No Social Media Guidance

    Updated: 2011-12-07 16:01:06
    Earlier this week, HHS Secretary Kathleen Sebelius gave a speech about the use of mobile information technology in healthcare. She lauded the advancements made in this field, from health IT in doctors’offices to iPad apps that help patients quit smoking.  Clearly, HHS recognizes the value of these tools, including social media, to improve healthcare. read more

  • Book Review: Roaccutane: The Truth, by Stefan Lay

    Updated: 2011-12-06 16:51:33
    The new ebook Roaccutane: The Truth, by Stefan Lay of Norwich, United Kingdom, offers an honest and informative view from a patient’s (or should we say victim?) perspective on the side effects of the acne drug Accutane (Roaccutane in the UK and Europe, generic isotretinoin) which I have written about previously on this blog. Stefan [...]

  • Actos expected to generate many more American lawsuits

    Updated: 2011-12-05 20:50:22
    Skip to navigation Skip to content Jump to Navigation Actos expected to generate many more American lawsuits On behalf of Tracey Law Firm posted in Dangerous Drugs 05 December 2011 Pharmaceutical giant Takeda Pharmaceutical Co . may soon be facing thousands of lawsuits in U.S . courts over its diabetes medication Actos . U.S . regulators reportedly found earlier this year that the diabetes medication increased patients' risk of developing bladder . cancer Actos , considered the world's best-selling diabetes drug , was pulled from the market earlier this year in Germany and France after the increased risk was discovered . Back in September , the company reported that it had already been sued 54 times over the drug in federal courts in the United . States Thousands more are expected to be

  • Medicare Part D Enrollment Period Ending Wednesday

    Updated: 2011-12-05 15:34:17
    As you may be aware, the 2012 open enrollment period for Medicare Part D ends this Wednesday, December 7th - three weeks earlier than in previous years. So in this busy holiday season, please also take a moment to sign up for a Part D drug plan. Remember, you can switch plans during the open enrollment period as well, so review your current plan to make sure it still meets your medical needs.  Next year, average monthly premiums in the program will remain low, costing on average $30 a month-- a little less than this year. read more

  • One Year After U.S. and Australian Recalls of Hip Implants, Australia Demands that DePuy Help Victims

    Updated: 2011-12-05 12:46:03
    . , Drug Recall Lawyer Blog Published by Miller Zois , LLC Home Website Practice Areas Contact Us Home DePuy Hip Implants Johnson Johnson One Year After U.S . and Australian Recalls of Hip Implants , Australia Demands that DePuy Help Victims Previous Home Next Posted On : December 5, 2011 by Ronald V . Miller , Jr . One Year After U.S . and Australian Recalls of Hip Implants , Australia Demands that DePuy Help Victims Share DePuy issued a U.S . recall of its metal-on-metal ASR hip implants in August of 2010 after 93,000 implant procedures because of an extremely high failure rate requiring patients to have revision surgeries . Evidence so far indicates that the device is exceedingly difficult for orthopaedic surgeons to implant properly . For background on the DePuy saga , see our DePuy

Current Feed Items | Previous Months Items

Nov 2011